These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 38488989)
21. Impact of penalizing factor in a block-sequential regularized expectation maximization reconstruction algorithm for Bjöersdorff M; Oddstig J; Karindotter-Borgendahl N; Almquist H; Zackrisson S; Minarik D; Trägårdh E EJNMMI Phys; 2019 Mar; 6(1):5. PubMed ID: 30900064 [TBL] [Abstract][Full Text] [Related]
22. Impact of a Bayesian penalized likelihood reconstruction algorithm on image quality in novel digital PET/CT: clinical implications for the assessment of lung tumors. Messerli M; Stolzmann P; Egger-Sigg M; Trinckauf J; D'Aguanno S; Burger IA; von Schulthess GK; Kaufmann PA; Huellner MW EJNMMI Phys; 2018 Sep; 5(1):27. PubMed ID: 30255439 [TBL] [Abstract][Full Text] [Related]
23. Phantom and clinical evaluation of Block Sequential Regularized Expectation Maximization (BSREM) reconstruction algorithm in 68Ga-PSMA PET-CT studies. Sadeghi F; Sheikhzadeh P; Kasraie N; Farzanehfar S; Abbasi M; Salehi Y; Ay M Phys Eng Sci Med; 2023 Sep; 46(3):1297-1308. PubMed ID: 37439965 [TBL] [Abstract][Full Text] [Related]
24. The added value of Kazmierczak PM; Rominger A; Wenter V; Spitzweg C; Auernhammer C; Angele MK; Rist C; Cyran CC Eur Radiol; 2017 Apr; 27(4):1676-1684. PubMed ID: 27436022 [TBL] [Abstract][Full Text] [Related]
25. Comparison of sequential planar 177Lu-DOTA-TATE dosimetry scans with 68Ga-DOTA-TATE PET/CT images in patients with metastasized neuroendocrine tumours undergoing peptide receptor radionuclide therapy. Sainz-Esteban A; Prasad V; Schuchardt C; Zachert C; Carril JM; Baum RP Eur J Nucl Med Mol Imaging; 2012 Mar; 39(3):501-11. PubMed ID: 22183108 [TBL] [Abstract][Full Text] [Related]
26. Radiotracer dose reduction in integrated PET/MR: implications from national electrical manufacturers association phantom studies. Oehmigen M; Ziegler S; Jakoby BW; Georgi JC; Paulus DH; Quick HH J Nucl Med; 2014 Aug; 55(8):1361-7. PubMed ID: 25006216 [TBL] [Abstract][Full Text] [Related]
27. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
28. Improved [ Li L; Chen R; Wen J; Yang X; Hu D; Sun H; Ge Q; Ng YL; Zhou Y; Wan L; Chen Y; Wei W; Liu J Quant Imaging Med Surg; 2023 Aug; 13(8):5230-5241. PubMed ID: 37581091 [TBL] [Abstract][Full Text] [Related]
30. Quantitative analysis of Ma G; Du J; Zhang X; Liu J; Xu X; Xu B; Guan Z Quant Imaging Med Surg; 2022 Apr; 12(4):2427-2440. PubMed ID: 35371938 [TBL] [Abstract][Full Text] [Related]
31. Comparison of Ga-68 DOTA-TATE and Ga-68 DOTA-LAN PET/CT imaging in the same patient group with neuroendocrine tumours: preliminary results. Demirci E; Ocak M; Kabasakal L; Araman A; Ozsoy Y; Kanmaz B Nucl Med Commun; 2013 Aug; 34(8):727-32. PubMed ID: 23728519 [TBL] [Abstract][Full Text] [Related]
32. Reduction of emission time for [68Ga]Ga-PSMA PET/CT using the digital biograph vision: a phantom study. Fragoso Costa P; Jentzen W; SÜßELBECK F; Fendler WP; Rischpler C; Herrmann K; Conti M; Kersting D; Weber M Q J Nucl Med Mol Imaging; 2023 Mar; 67(1):57-68. PubMed ID: 34309334 [TBL] [Abstract][Full Text] [Related]
34. Feasibility of acquisitions using total-body PET/CT with a half-dose [ Chen Z; Wang Y; Yang X; Li L; Huo Y; Yu X; Xiao X; Zhang C; Chen Y; Zhao H; Zhou Y; Huang G; Liu J; Chen R Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3961-3969. PubMed ID: 37535107 [TBL] [Abstract][Full Text] [Related]
35. Comparison of Regularized Reconstruction and Ordered Subset Expectation Maximization Reconstruction in the Diagnostics of Prostate Cancer Using Digital Time-of-Flight Jonmarker O; Axelsson R; Nilsson T; Gabrielson S Diagnostics (Basel); 2021 Mar; 11(4):. PubMed ID: 33807370 [TBL] [Abstract][Full Text] [Related]
36. Standard OSEM vs. regularized PET image reconstruction: qualitative and quantitative comparison using phantom data and various clinical radiopharmaceuticals. Lantos J; Mittra ES; Levin CS; Iagaru A Am J Nucl Med Mol Imaging; 2018; 8(2):110-118. PubMed ID: 29755844 [TBL] [Abstract][Full Text] [Related]
37. Synthesis, preclinical evaluation, and a pilot clinical imaging study of [ Xie Q; Liu T; Ding J; Zhou N; Meng X; Zhu H; Li N; Yu J; Yang Z Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3129-3140. PubMed ID: 33630145 [TBL] [Abstract][Full Text] [Related]
38. Sequential deep learning image enhancement models improve diagnostic confidence, lesion detectability, and image reconstruction time in PET. Dedja M; Mehranian A; Bradley KM; Walker MD; Fielding PA; Wollenweber SD; Johnsen R; McGowan DR EJNMMI Phys; 2024 Mar; 11(1):28. PubMed ID: 38488923 [TBL] [Abstract][Full Text] [Related]